These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34915638)

  • 1. [Clinical characteristics and prognostic analysis of double primary breast cancer and thyroid cancer].
    Zhai J; Kong XY; Fang Y; Wang J
    Zhonghua Zhong Liu Za Zhi; 2021 Dec; 43(12):1287-1291. PubMed ID: 34915638
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased expression of thyroid hormone receptor alpha and estrogen receptor alpha in breast cancer associated with thyroid cancer.
    Kim YA; Kim YA; Cho SW; Song YS; Min HS; Park IA; Park DJ; Hwang KT; Park YJ
    Eur J Surg Oncol; 2021 Jun; 47(6):1316-1323. PubMed ID: 33558123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and survival of patients with metachronous or synchronous double primary malignancies: breast and thyroid cancer.
    Zhang L; Wu Y; Liu F; Fu L; Tong Z
    Oncotarget; 2016 Aug; 7(32):52450-52459. PubMed ID: 27223440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer prognosis is better in patients who develop subsequent metachronous thyroid cancer.
    Lei K; He X; Yu L; Ni C; Chen H; Guan D; Sun K; Zou H
    PLoS One; 2019; 14(5):e0215948. PubMed ID: 31042767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Breast Cancer Family History, Estrogen Receptor Status, and Breast Cancer Outcomes in Sweden.
    Zhang Y; Wang QL; Zeng E; He W; Czene K
    JAMA Netw Open; 2023 Jun; 6(6):e2318053. PubMed ID: 37310740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database.
    Li S; Yang J; Shen Y; Zhao X; Zhang L; Wang B; Li P; Wang Y; Yi M; Yang J
    BMC Public Health; 2019 Nov; 19(1):1592. PubMed ID: 31783815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.
    Li Y; Yang D; Yin X; Zhang X; Huang J; Wu Y; Wang M; Yi Z; Li H; Li H; Ren G
    JAMA Netw Open; 2020 Jan; 3(1):e1918160. PubMed ID: 31899528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
    Karatas F; Erdem GU; Sahin S; Aytekin A; Yuce D; Sever AR; Babacan T; Ates O; Ozisik Y; Altundag K
    Breast; 2017 Apr; 32():237-244. PubMed ID: 27318645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival Outcomes in Thyroid Cancer Patients with Co-Occurring Breast Cancer: Evidence of Mortality Risk Attenuation.
    Baumgarten MW; Goemann IM; Scheffel RS; Maia AL
    Clin Breast Cancer; 2024 Aug; 24(6):e519-e527. PubMed ID: 38670860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation of
    Qu YH; Long N; Ran C; Sun J
    Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
    Griguolo G; Pouderoux S; Dieci MV; Jacot W; Bourgier C; Miglietta F; Firmin N; Conte P; Viala M; Guarneri V; Darlix A
    Oncologist; 2018 Nov; 23(11):1289-1299. PubMed ID: 30120164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased breast cancer-specific mortality risk in patients with a history of thyroid cancer.
    Cheng W; Shen X; Xing M
    PLoS One; 2019; 14(10):e0221093. PubMed ID: 31644578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between breast cancer and thyroid cancer: A study based on 13 978 patients with breast cancer.
    Huang NS; Chen XX; Wei WJ; Mo M; Chen JY; Ma B; Yang SW; Xu WB; Wu J; Ji QH; Guo XM; Liu GY; Shao ZM; Wang Y
    Cancer Med; 2018 Dec; 7(12):6393-6400. PubMed ID: 30480382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of clinicopathological features and prognostic factors of breast cancer brain metastasis.
    Chen YR; Xu ZX; Jiang LX; Dong ZW; Yu PF; Zhang Z; Gu GL
    World J Clin Oncol; 2023 Nov; 14(11):445-458. PubMed ID: 38059189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPFIA1 is upregulated in liver metastasis of breast cancer and is a potential poor prognostic indicator of metastatic relapse.
    Yang J; Wu NN; Huang DJ; Luo YC; Huang JZ; He HY; Lu HL; Song WL
    Tumour Biol; 2017 Jul; 39(7):1010428317713492. PubMed ID: 28720060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of clinicopathological characteristics and family history data of early-onset breast cancer: a single-institutional study of Hungarian patients.
    Madaras L; Baranyák Z; Kulka J; Szász AM; Kovács A; Lan PH; Székely B; Dank M; Nagy T; Kiss O; Harsányi L; Barbai T; Kenessey I; Tőkés AM
    Pathol Oncol Res; 2013 Oct; 19(4):723-9. PubMed ID: 23709114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and survival analysis of breast cancer survivors with metachronous double primary cancers: a retrospective cohort study.
    Song Y; Wang J; Wang X; Li R; Niu X; Yang Y; Yang X; Yin L; Wang Y; Zhang H; Shui R; Zhang C; An J
    Transl Cancer Res; 2023 Apr; 12(4):939-948. PubMed ID: 37180649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognosis and risk factors of 1 791 patients with breast cancer treated with breast-conserving surgery based on real-world data].
    Chen SY; Tang Y; Song YW; Wang SL; Jin J; Liu YP; Wang WH; Fang H; Ren H; Sun GY; Wang JY; Jing H; Zhang JH; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):619-625. PubMed ID: 30139034
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to neoadjuvant chemotherapy based on pathologic complete response in very young patients with ER-positive breast cancer: a large, multicenter, observational study.
    Woo J; Oh SJ; Song JY; Chae BJ; Choi JE; Lee J; Park HK; ; Lim W
    BMC Cancer; 2021 May; 21(1):647. PubMed ID: 34059020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.